<!DOCTYPE html><html><head><title>End stage renal disease (ESRD): adjusted percentage of adult hemodialysis patient-months using an autogenous arteriovenous fistula (AVF) as the sole means of vascular access.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Title
</h3>
<div class='FieldValue'>
<div class="content_title">End stage renal disease (ESRD): adjusted percentage of adult hemodialysis patient-months using an autogenous arteriovenous fistula (AVF) as the sole means of vascular access.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Centers for Medicare & Medicaid Services (CMS). Measure information form: hemodialysis vascular access: standardized fistula rate. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2016 Apr 15. 58 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Measure Domain
</h2>
<div class='field field_picklist-one'>
<h3>
Primary Measure Domain
</h3>
<div class='FieldValue'>
Clinical Quality Measures: Process
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Secondary Measure Domain
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>Brief Abstract
</h2>
<div class='field field_text'>
<h3>
Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure is used to assess the adjusted percentage of adult hemodialysis patient-months using an autogenous arteriovenous fistula (AVF) as the sole means of vascular access.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rationale
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines state the following: </p>
<ol style="list-style-type: decimal;" start="1">
    <li>Arteriovenous (AV) fistulas (AVFs) have the lowest rate of thrombosis and require the fewest interventions, </li>
    <li>Cost of AV fistula use and maintenance is the lowest, </li>
    <li>Fistulas have the lowest rates of infection, and </li>
    <li>Fistulas are associated with the highest survival and lowest hospitalization rates. </li>
</ol>
<p>Indeed, a number of epidemiologic studies consistently demonstrate the reduced morbidity and mortality associated with greater use of AVFs for vascular access in maintenance hemodialysis.</p>
<p>As the accompanying literature review indicates, there are a growing number of studies reporting that creating AVF in some patients is less likely to be successful in the presence of certain comorbidities. In addition, certain patient groups may have less incremental benefit from an AVF relative to an AV graft. By adjusting the fistula rate for patient characteristics and comorbidities associated with low AV fistula success rates, this measure accounts for patients where a graft or even a catheter may be a more appropriate option.</p>
<p>This measure is intended to be jointly reported with Hemodialysis Vascular Access: Long-term Catheter Rate (see the related NQMC summary, <a href="/summaries/summary/51319" title="Measure Summary #11397" target="_blank">End stage renal disease [ESRD]: percentage of adult hemodialysis patient-months using a catheter continuously for three months or longer for vascular access</a>). These two vascular access quality measures, when used together, consider AVF use as a positive outcome and prolonged use of a tunneled catheter as a negative outcome. With the growing recognition that some patients have exhausted options for an AVF or have comorbidities that may limit the success of AVF creation, joint reporting of the measures accounts for all three vascular access options. The fistula measure adjusts for patient factors where fistula placement may be either more difficult or not appropriate and acknowledges that in certain circumstances an AV graft may be the best access option. This paired incentive structure that relies on both measures (standardized fistula rate [SFR], long-term catheter rate) reflects consensus best practice, and supports maintenance of the gains in vascular access success achieved via the Fistula First/Catheter Last Project over the last decade.</p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Rationale
</h3>
<div class='FieldValue'>
<table><tr><td>National Quality Forum measure information form: hemodialysis vascular access: standardized fistula rate. Washington (DC): National Quality Forum (NQF); 2018 Feb 1. various p. </td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Primary Health Components
</h3>
<div class='FieldValue'>
<div class="content_para"><p>End stage renal disease (ESRD); hemodialysis (HD); autogenous arteriovenous fistula (AVF)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>All patients at least 18 years old as of the first day of the reporting month who are determined to be maintenance hemodialysis (HD) patients (in-center and home HD) for the complete reporting month at the same facility (see the related "Denominator Inclusions/Exclusions" field)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The numerator is the adjusted count of adult patient-months using an arteriovenous fistula (AVF) as the sole means of vascular access as of the last hemodialysis treatment session of the month (see the related "Numerator Inclusions/Exclusions" field)</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Type of Evidence Supporting the Criterion of Quality for the Measure
</h3>
<div class='FieldValue'>
A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence
</div>
<div class='FieldValue'>
A systematic review of the clinical research literature (e.g., Cochrane Review)
</div>
<div class='FieldValue'>
One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal
</div>

</div>
<div class='field field_text'>
<h3>
Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Extent of Measure Testing
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Reliability Testing</strong></p>
<p><em>Method of Reliability Testing</em></p>
<p>The developer used January 2014&ndash;December 2014 CROWNWeb data to calculate facility-level annual performance scores. The National Quality Forum (NQF)-recommended approach for determining measure reliability is a one-way analysis of variance (ANOVA), in which the between-facility variation (&sigma;_b^2) and the within-facility variation (&sigma;_(t,w)^2) in the measure is determined. The inter-unit reliability (IUR) measures the proportion of the total variation of a measure (i.e., &sigma;_b^2 + &sigma;_(t,w)^2) that is attributable to the between-facility variation, the true signal reflecting the differences across facilities. The developer assessed reliability by calculating inter-unit reliability (IUR) for the annual performance scores. A small IUR (near 0) reveals that most of the variation of the measure between facilities is driven by random noise, indicating the measure would not be a good characterization of the differences among facilities, whereas a large IUR (near 1) indicates that most of the variation between facilities is due to the real difference between facilities.</p>
<p>The reliability of standardized fistula rate (SFR) calculation only included facilities with at least 11 patients during the entire year.</p>
<p><em>Statistical Results from Reliability Testing</em></p>
<p>The IUR is 0.736 which indicates that about 74% of the variation in the annual SFR can be attributed to between-facility differences in performance (signal) and about 26% to the within-facility variation (noise).</p>
<p><em>Interpretation</em></p>
<p>The result of IUR testing suggests a high degree of reliability.</p>
<p><strong>Validity Testing</strong></p>
<p><em>Method of Validity Testing</em></p>
<p>Validity was assessed using Poisson regression models to measure the association between facility level quintiles of performance scores and the 2014 standardized mortality ratio (SMR, NQF 0369) and 2014 standardized hospitalization ratio (SHR, NQF 1463). Facility-level performance scores were divided into quintiles (Q1 to Q5) and the relative risk (RR) of mortality (and hospitalization, separately) was calculated for each quintile, using the combined Q4 and Q5 as the reference group. Thus, a RR greater than 1.0 would indicate a higher RR of mortality or hospitalization, compared to the highest performance score quintiles.</p>
<p>In 2015, a vascular access technical expert panel (TEP) was convened to provide input on the development of access measures, and specifically input on exclusions for both catheter and fistula measures, and for fistula, risk adjustment factors to be considered. Ultimately, evaluation and selection of the clinical and patient risk factors for this measure was informed by the final TEP recommendations. The TEP recognized that while fistulas are preferred, an unintended consequence of a fistula measure that doesn't account for the patient's overall health status could harm patients by subjecting them to fistula surgery that is less likely to succeed or limit access to care for patients with more comorbidities. To accomplish this goal, the TEP discussed adjusting the measure for conditions or scenarios where a graft may be an acceptable or preferred alternative to a fistula. The candidate measure was reviewed and validated by the TEP in 2015.</p>
<p><em>Statistical Results from Validity Testing</em></p>
<p>Quintiles of the performance scores were defined as follows:</p>
<ul style="list-style-type: disc;">
    <li>Q1: 9.2% - less than 55.9% </li>
    <li>Q2: 55.9% - less than 62.0% </li>
    <li>Q3: 62.0% - less than 67.4% </li>
    <li>Q4*: 67.4% - less than 73.4% </li>
    <li>Q5*: 73.4% - less than 97.5% </li>
</ul>
<p>*Q4 and Q5 as reference</p>
<p>Results from the Poisson model indicated that the percent of patient-months with a fistula was significantly associated with the risks of mortality and hospitalization.</p>
<p>For the 2014 SMR, the RR of mortality increased as the performance measure quintile decreased from the reference group (combined Q4 and Q5) with the highest risk in quintile 1. For quintile 3, RR = 1.03 (95% CI: 1.01, 1.05; p = 0.003), quintile 2, RR = 1.05 (95% CI: 1.03, 1.07; p less than 0.001), and quintile 1, RR = 1.10 (95% CI: 1.08, 1.12; p less than 0.001).</p>
<p>Similarly for 2014 SHR, the RR of hospitalization increased as the performance measure quintile decreased from the reference group (combined Q4 and Q5) with the highest risk in quintile 1. For quintile 3, RR = 1.07 (95% CI: 1.06, 1.07; p less than 0.001), quintile 2, RR = 1.08 (95% CI: 1.08, 1.09; p less than 0.001), and quintile 1, RR = 1.11 (95% CI: 1.11, 1.11; p less than 0.001).</p>
<p><em>Interpretation</em></p>
<p>These results of the Poisson regression suggest the predictive relationship of lower fistula use with higher mortality and hospitalization, as measured by the respective standardized mortality and hospitalization rates, and compared to facilities with higher fistula use.</p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Extent of Measure Testing
</h3>
<div class='FieldValue'>
<table><tr><td>National Quality Forum measure information form: hemodialysis vascular access: standardized fistula rate. Washington (DC): National Quality Forum (NQF); 2018 Feb 1. various p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>State of Use of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
State of Use
</h3>
<div class='FieldValue'>
Current routine use
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Current Use
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Application of the Measure in its Current Use
</h2>
<div class='field field_picklist-choice'>
<h3>
Measurement Setting
</h3>
<div class='FieldValue'>
Ambulatory Procedure/Imaging Center
</div>
<div class='FieldValue'>
Hospital Outpatient
</div>
<div class='FieldValue'>
Managed Care Plans
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Professionals Involved in Delivery of Health Services
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Least Aggregated Level of Services Delivery Addressed
</h3>
<div class='FieldValue'>
Single Health Care Delivery or Public Health Organizations
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Statement of Acceptable Minimum Sample Size
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_text'>
<h3>
Target Population Age
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Age greater than or equal to 18 years</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Target Population Gender
</h3>
<div class='FieldValue'>
Either male or female
</div>

</div>

</div>
<div class='section'>
<h2>National Strategy for Quality Improvement in Health Care
</h2>
<div class='field field_text'>
<h3>
National Quality Strategy Aim
</h3>
<div class='FieldValue'>
<ul><li>Better Care</li></ul>
</div>

</div>
<div class='field field_text'>
<h3>
National Quality Strategy Priority
</h3>
<div class='FieldValue'>
<ul><li>Prevention and Treatment of Leading Causes of Mortality</li></ul>
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Health Care Quality Report Categories
</h2>
<div class='field field_picklist-choice'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Living with Illness
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>

</div>

</div>
<div class='section'>
<h2>Data Collection for the Measure
</h2>
<div class='field field_text'>
<h3>
Case Finding Period
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The reporting month</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Sampling Frame
</h3>
<div class='FieldValue'>
Patients associated with provider
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Denominator (Index) Event or Characteristic
</h3>
<div class='FieldValue'>
Patient/Individual (Consumer) Characteristic
</div>
<div class='FieldValue'>
Therapeutic Intervention
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Denominator Time Window
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
All patients at least 18 years old as of the first day of the reporting month who are determined to be maintenance hemodialysis (HD) patients (in-center and home HD) for the complete reporting month at the same facility</p>
<p>Patients are required to have been treated by the same facility for the complete month in order to be assigned to that facility for the reporting month.</p>
<p>The monthly patient count at a facility includes all eligible prevalent and incident patients. The number of patient-months over a time period is the sum of patients reported for the months covered by the time period. An individual patient may contribute up to 12 patient-months per year.</p>
<p><strong>Exclusions</strong><br />
Exclusions that are implicit in the denominator definition include:</p>
<ul style="list-style-type: disc;">
    <li>Pediatric patients (less than 18 years old) </li>
    <li>Patients on peritoneal dialysis </li>
    <li>Patient-months under in-center or home HD for less than a complete reporting month at the same facility </li>
</ul>
<p>In addition, the following exclusions are applied to the denominator:</p>
<p>Patients with a catheter that have limited life expectancy:</p>
<ul style="list-style-type: disc;">
    <li>Patients under hospice care in the current reporting month </li>
    <li>Patients with metastatic cancer in the past 12 months </li>
    <li>Patients with end stage liver disease in the past 12 months </li>
    <li>Patients with coma or anoxic brain injury in the past 12 months </li>
</ul></div>
</div>

</div>
<div class='field field_picklist-choice-4'>
<h3>
Exclusions/Exceptions
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
The numerator is the adjusted count of adult patient-months using an arteriovenous fistula (AVF) as the sole means of vascular access as of the last hemodialysis treatment session of the month </p>
<p>The number of patient-months using an autogenous arteriovenous fistula (AVF) as the sole means of vascular access at a given facility, adjusted for patient-mix.</p>
<p>An AVF is considered in use if the CROWNWeb "Access Type IDs" of 14 or 22 has been recorded for a given month, where "14" represents AV fistula only (with 2 needles) and "22" represents AV fistula only with an approved single needle device.</p>
<p><strong>Exclusions</strong><br />
Unspecified</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Numerator Search Strategy
</h3>
<div class='FieldValue'>
Fixed time period or point in time
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Data Source
</h3>
<div class='FieldValue'>
Administrative clinical data
</div>
<div class='FieldValue'>
Electronic health/medical record
</div>
<div class='FieldValue'>
Registry data
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Type of Health State
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_text'>
<h3>
Instruments Used and/or Associated with the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Calculation Flow Chart: Hemodialysis Vascular Access: Standardized Fistula Rate</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Computation of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Measure Specifies Disaggregation
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Scoring
</h3>
<div class='FieldValue'>
Rate/Proportion
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Interpretation of Score
</h3>
<div class='FieldValue'>
Desired value is a higher score
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Description of Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure is a directly standardized percentage, in that each facility's percentage of autogenous arteriovenous fistula (AVF) use is adjusted to the national distribution of covariates (risk factors) (with 'national' here referring to all-facilities-combined). The SFR for facility is an estimate of what the facility's percentage of AVF would equal if the facility's patient mix was equal to that of the nation as a whole. The measure is adjusted for patient demographic and clinical characteristics based on a logistic regression model. This model includes the facility indicators and assumes that the regression coefficients of risk factors are the same across all facilities. The common risk effects are assumed in order to improve computational stability in estimating facility-specific effects.</p>
<p>The patient characteristics included in the logistic regression model as covariates are:</p>
<ul style="list-style-type: disc;">
    <li>Age </li>
    <li>Body mass index (BMI) at incidence </li>
    <li>Nursing home status in previous year </li>
    <li>Nephrologist's care prior to end stage renal disease (ESRD) </li>
    <li>Duration of ESRD </li>
    <li>Inability to ambulate/transfer at ESRD incidence </li>
    <li>Comorbidities either at ESRD incidence or prevalent comorbidities based on Medicare claims filed in prior 12 months
    <ul style="list-style-type: disc;">
        <li>Diabetes </li>
        <li>Heart diseases </li>
        <li>Peripheral vascular disease </li>
        <li>Cerebrovascular disease </li>
        <li>Chronic obstructive pulmonary disease </li>
        <li>Anemia (unrelated to ESRD/chronic kidney disease [CKD]) </li>
        <li>Non-vascular access-related infections </li>
        <li>Drug dependence </li>
    </ul>
    </li>
    <li>Indicator for Medicare coverage for at least six months during the past 12 months </li>
</ul></div>
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Standard of Comparison
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information
</h2>
<div class='field field_text'>
<h3>
Original Title
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Hemodialysis vascular access: standardized fistula rate.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Collection Name
</h3>
<div class='FieldValue'>
End Stage Renal Disease (ESRD) Quality Measures
</div>

</div>
<div class='field field_orglist'>
<h3>
Submitter
</h3>
<div class='FieldValue'>
Centers for Medicare & Medicaid Services - Federal Government Agency [U.S.]
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Developer
</h3>
<div class='FieldValue'>
Centers for Medicare & Medicaid Services - Federal Government Agency [U.S.]
</div>

</div>
<div class='field field_text'>
<h3>
Funding Source(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Centers for Medicare &amp; Medicaid Services (CMS)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of the Group that Developed the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Joseph Vassalotti, MD, FASN, FNKF<br />
Chief Medical Officer, National Kidney Foundation<br />
Associate Professor of Medicine, Division of Nephrology<br />
Mount Sinai Medical Center<br />
New York, NY</p>
<p>Monet Carnahan, RN, BSN, CDN<br />
Renal Care Coordinator Program Manager<br />
Fresenius Medical Center (FMC)<br />
Franklin, TN<br />
American Nephrology Nurses Association</p>
<p>Derek Forfang<br />
Patient Leadership Committee Chair, ESRD Network 17<br />
Board Member, Intermountain End State Renal Disease Network Inc.<br />
Beneficiary Advisory Council (Vice Chair), The National Forum of ESRD Networks<br />
Board Member, The National Forum of ERSD Networks<br />
San Pablo, CA</p>
<p>Lee Kirskey, MD<br />
Attending staff, Department of Vascular Surgery<br />
Cleveland Clinic Foundation<br />
Cleveland, OH</p>
<p>Nance Lehman<br />
Board Member<br />
Dialysis Patient Citizens (DPC)<br />
Billings, MT</p>
<p>Charmaine Lok, MD, MSc, FRCPC (C)<br />
Medical Director of Hemodialysis and Renal Management Clinics<br />
University Health Network<br />
Professor of Medicine<br />
University of Toronto<br />
Toronto, ON</p>
<p>Lynn Poole, FNP-BC, CNN NCC<br />
Fistula First Catheter Last Project Clinical Lead<br />
ESRD National Coordinating Center<br />
Lake Success, NY</p>
<p>Rudy Valentini, MD<br />
Chief Medical Officer<br />
Children's Hospital of Michigan (CHM)<br />
Professor of Pediatrics, Division of Nephrology<br />
Wayne State University School of Medicine</p>
<p>Daniel Weiner, MD, MS<br />
Nephrologist, Tufts Medical Center<br />
Associate Medical Director, DCI Boston<br />
Associate Professor of Medicine, Tufts University School of Medicine <br />
Boston, MA</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Other Potential Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_orglist'>
<h3>
Endorser
</h3>
<div class='FieldValue'>
National Quality Forum - None
</div>

</div>
<div class='field field_plain-text'>
<h3>
NQF Number
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Date of Endorsement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>2016 Dec 9</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_date'>
<h3>
Date of Most Current Version in NQMC
</h3>
<div class='FieldValue'>
2016 Apr
</div>

</div>
<div class='field field_text'>
<h3>
Measure Maintenance
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Annually</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date of Next Anticipated Revision
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the measure.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Source available from the <a href="https://www.dialysisdata.org/content/esrd-measures" title="Dialysis Data Web site">Dialysis Data Web site</a>.</p>
<p>For more information, contact Casey Parrotte at the Kidney Epidemiology and Cost Center, The University of Michigan, 1415 Washington Heights, Suite 3645 SPHI, Ann Arbor, MI 48109-2029; Phone: 734-763-6611; Fax: 734-763-4004; Email: <a href="mailto:parrotte@med.umich.edu">parrotte@med.umich.edu</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NQMC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary was completed by ECRI Institute on May 22, 2018. The information was not verified by the measure developer.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>No copyright restrictions apply.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Production
</h2>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Centers for Medicare & Medicaid Services (CMS). Measure information form: hemodialysis vascular access: standardized fistula rate. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2016 Apr 15. 58 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NQMC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Quality Measures Clearinghouseâ„¢ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>
</div>

</div>

</div>
</body></html>